Related Experiment Video
Updated: May 8, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after
Ya-chen Zhang1, Yong Tang, Yu Chen
1Division of Cardiology, Xinhua Hospital School of Medicine, Shanghai Jiaotong University, 1665 Kong Jiang Road, Shanghai, 200092, China, zhangyachen1965@163.com.
Insights
Elevated oxidized low-density lipoprotein (Ox-LDL) and high-sensitivity C-reactive protein (hs-CRP) predict cardiovascular events in acute coronary syndrome (ACS) patients. Combining Ox-LDL and hs-CRP offers the strongest prediction for major adverse cardiovascular events.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Research
Background:
- Elevated oxidized low-density lipoprotein (Ox-LDL) and high-sensitivity C-reactive protein (hs-CRP) are known predictors of cardiovascular events in acute coronary syndrome (ACS) patients.
- The combined predictive value of Ox-LDL and hs-CRP for cardiovascular events in ACS patients remains underexplored.
Purpose of the Study:
- To investigate the combined predictive value of Ox-LDL and hs-CRP for cardiovascular events in ACS patients.
- To compare the predictive performance of Ox-LDL and hs-CRP, individually and combined, against cardiac troponin T (cTnT).
Main Methods:
- A prospective cohort study involving 425 ACS patients followed for 3-5 years.
- Serum concentrations of Ox-LDL, hs-CRP, and cTnT were measured at baseline.
- Kaplan-Meier survival analysis and receiver-operating characteristic (ROC) curve analysis were used to assess predictive values.
Main Results:
- 124 out of 425 patients experienced major adverse cardiovascular events (acute myocardial infarction or death).
- Baseline Ox-LDL, hs-CRP, and cTnT levels were significantly higher in patients who experienced events.
- Combined assessment of Ox-LDL and hs-CRP demonstrated the strongest risk prediction, outperforming individual markers and cTnT (AUCs: Ox-LDL 0.891, hs-CRP 0.834, cTnT 0.626).
Conclusions:
- Elevated Ox-LDL and hs-CRP levels are significant predictors of cardiovascular events post-ACS.
- The combined use of Ox-LDL and hs-CRP provides superior prognostic value for cardiovascular events compared to individual markers or cTnT.
- Combining Ox-LDL and hs-CRP may enhance the prediction of prognosis in ACS patients with high sensitivity and specificity.
Abstract:
It has been shown that the elevated concentrations of oxidized low-density lipoprotein (Ox-LDL) or high-sensitivity C-reactive protein (hs-CRP) are predictive of future cardiovascular events for acute coronary syndrome (ACS) patients. But, the combined value of Ox-LDL and hs-CRP for predicting cardiovascular events is still unknown. Serum concentrations of Ox-LDL, hs-CRP, and cTnT were measured in a prospective cohort of 425 selective ACS patients followed 3-5 years for the occurrence of acute myocardial infarction (AMI) or death (AMI/death). Among 425 enrolled patients, 124 patients demonstrated AMI/death. Baseline levels of Ox-LDL, hs-CRP, and cTnT were significantly higher in AMI/death group than the event-free survival group. Kaplan-Meier survival analyses supported that elevations in Ox-LDL or hs-CRP predicted increased cardiovascular events risks. However, the strongest risk prediction was achieved by assessing Ox-LDL and hs-CRP together. Patients with high levels of Ox-LDL and hs-CRP were more likely to experience AMI or death than those with either Ox-LDL or hs-CRP elevated. Receiver-operating characteristic curves showed that Ox-LDL and hs-CRP have higher sensitivity and specificity than those of cTnT for predicting AMI or death. This was reflected by the AUC values for Ox-LDL, hs-CRP, and cTnT, which were 0.891, 0.834, and 0.626, respectively. The combined use of Ox-LDL and hs-CRP may improve prognosis after ACS with high-sensitivity and specificity.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
